Value, European, Healthcare, Market

How to develop a compelling value proposition in the current European healthcare market

At Evidence EU 2014, Caroline Gadd, Otsuka Pharmaceuticals, gave a presentation on “How to develop a compelling value proposition in the current European healthcare market”. Gadd’s presentation highlights the importance of value proposition, demonstrating that a successful proposition is moving towards a customer centric approach as well as being able to support the whole market. Download and Learn: The value proposition as …

competitive, generics, market

Small is beautiful: Winning in the highly competitive generics market

At the World Generic Medicines Congress Europe 2014, John Beighton, CEO,  Amdipharm Mercury Company Ltd gave a presentation on “Small is beautiful: Winning in the highly competitive generics market” Beighton’s presentation explores an entrepreneur’s dilemma of “How to grow without losing the “spirit” of what creates value” Download and learn: Strategic Growth Background: The In-market value chain Global Coverage Five Distinct go-to-market approaches for …

Growth of orphan drug market puts the World Orphan Drug Congress USA in the spotlight

Differently from the uncertainty of the economic growth across developed countries, the pharmaceutical industry is optimistic about the increasing revenue from orphan drug development. In a recent report conducted by BCC Research, the orphan drug market in 2012 was evaluated in $82 billion and is expected to grow at an average rate of 5.4% in the next five years, to …

Biocomparable Market in Mexico: Bills and Changes

  There have been many changes in Mexico's biocomparable market in Mexico. In their article "Moving Forward: biologics and biocomparables in Mexico" Daniel Sanchez and Vicotr Ramirez discuss this trend. Although some provisions have been enacted, there are many things left to do and many of these are currently under discussion in industry and government. In fact, there is a …